These observations derive from preclinical and in vitro research and characterize the compounds studied biochemistry rather than any therapeutic effect
Jacqueline Maya, M.D., from Massachusetts General Hospital-Mass General Brigham in Boston, and colleagues conducted a retrospective cohort study of 149,790 singleton pregnancies delivered between June 1, 2016, and March 31, 2025, to compare weight gain and pregnancy outcomes with and without exposure to GLP-1 RAs before or during early pregnancy
Streamline patient onboarding with digital assessments, reducing administrative bottlenecks
Biote NAD+ 300 Benefits of NAD+ 300 & NAD+ 1000 For patients already optimizing hormones, sleep, and nutrition, NAD+ 300 & NAD+ 1000 help fill the gap when energy dips or recovery slows
Role of chronic cannabis use: Cyclic vomiting syndrome vs cannabinoid hyperemesis syndrome